Skip to main content

GOLDMAN SACHS GROUP INC

Position in CLDX — Celldex Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in CLDX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$60,106,911
+$28,754,357 QoQ
Shares Held
1,615,343
+63.4% QoQ
Ownership
2.06%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#12
of 252 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 98% Shared 1% None 0%

Common Shares in CLDX Over Time

Shares Held

Position Value (USD)

Derivatives in CLDX

reported options exposure · as of Dec 31, 2024
CallValue
$0
CallShares
0
PutValue
$636,804
PutShares
25,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. CLDX ranks #57 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CLDX

Export CSV
29 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $60,106,911 1,615,343
2026-03-31 $31,352,554 988,416
2025-12-31 $29,010,437 1,068,131
2025-09-30 $26,632,130 1,029,460
2025-06-30 $14,804,706 727,504
2025-03-31 $12,632,526 696,007
2024-12-31 $636,804 25,200
2024-12-31 $30,385,986 1,202,453
2024-09-30 $856,548 25,200
2024-09-30 $62,400,302 1,835,843
2024-06-30 $32,353,882 874,193
2024-06-30 $932,652 25,200
2024-03-31 $23,704,781 564,803
2024-03-31 $1,057,644 25,200
2023-12-31 $17,361,521 437,759
2023-12-31 $999,432 25,200
2023-09-30 $11,333,670 411,834
2023-06-30 $15,027,596 442,900
2023-03-31 $12,959,024 360,173
2022-12-31 $20,037,958 449,584
2022-09-30 $18,677,155 664,431
2022-06-30 $11,854,635 439,712
2022-03-31 $10,334,450 303,419
2021-12-31 $9,822,828 254,214
2021-09-30 $16,611,588 307,679
2021-06-30 $11,304,559 338,055
2021-03-31 $9,658,948 468,881
2020-12-31 $11,253,148 642,303
2020-09-30 $1,531,301 103,257